The present tumor cell viability assays demonstrated GLI inhibition by GANT61 in a time- and concentration-dependent manner, as evidenced by significantly reduced numbers of viable HSC3 cells compared to negative controls after 24 h of treatment at both evaluated concentrations. This evidence concerns the gene GLI1 and neoplasm.